PedAM
Pediatric Disease Annotations & Medicines
| Disease | gout |
| Phenotype | C0022661|chronic kidney disease |
| Sentences | 10 |
| PubMedID- 21812963 | chronic kidney disease in gout in a managed care setting. |
| PubMedID- 25889144 | gout was associated with both chronic kidney disease (pooled adjusted odds ratio 2.41, 95% confidence interval 1.86 to 3.11) and self-reported lifetime nephrolithiasis (1.77, 1.43 to 2.19). |
| PubMedID- 24433285 | The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study. |
| PubMedID- 26176346 | Background: the aim of this study was to investigate the relationship between central blood pressure, arterial stiffness parameters and renal function parameters in gout patients with chronic kidney disease (ckd) and without ckd. |
| PubMedID- 22627199 | The aim of this study was to explore the pathophysiological characteristics of cxcl16 in gout patients with or without chronic kidney disease (ckd). |
| PubMedID- 23370375 | An appreciation that hyperuricaemia and gout are associated with hypertension and chronic kidney disease is well established, but the cause and effect relationships are controversial. |
| PubMedID- 21462517 | [treatment of gout in patients with chronic kidney disease]. |
| PubMedID- 21694941 | Other factors that may contribute to the relatively low rate of hyperuricemia and gout in patients with chronic kidney disease (ckd) include lower protein intake and increased intestinal clearance of uric acid. |
| PubMedID- 23982888 | chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study. |
| PubMedID- 26453097 | Despite the fact that it has been available for over 40 years there is ongoing debate about optimal allopurinol dosing in gout patients with chronic kidney disease. |
Page: 1